The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

Novavax NVAX is scheduled to report third-quarter 2024 earnings on Nov. 12, before the opening bell. In the last reported ...

Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back against the vaccine.

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, ...

WASHINGTON — If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s ...

A new large study of children in California shows that unvaccinated kids are at a much higher risk of developing multisystem ...

PHILADELPHIA — The same technology that saved millions of lives during the COVID-19 pandemic appears to hold promise against another scourge of infectious disease, according to new research from the ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

The optimal time to get your seasonal flu shot, according to the Food and Drug Administration (FDA), is right now: flu ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

Both stocks have made significant breakthroughs. Among the qualities a biotech company needs to be successful, being innovative is one of the most important. It's easy to understand why. Although ...

Evidence shows that the vaccines used in Canada are very effective at preventing severe illness, hospitalization and death from COVID-19. It's important to receive a primary series and a booster dose ...